Development of blood tests for early lung cancer
Development of blood tests for early lung cancer
Atezolizumab with chemotherapy improves PFS in squamous NSCLC
Editor's Choice for April 2018
Neoadjuvant nivolumab for resectable lung cancer
The importance of online patient groups and 'The ROS1ders'
Effects of dasatinib on xenograft lung tumour models with YES1 overexpression
Response and safety profile of neoadjuvant nivolumab for resectable lung cancer
Doubled survival in metastatic lung cancer with combination therapy
Combined immuno-chemotherapy improves survival and responses in metastatic lung cancer
Results from CheckMate-227 : Immune combination reaches PFS endpoint
How the SBIR development centre funds cancer initiatives
Editor's Choice for February 2018